Marriott Harrison LLP advises Zeus Capital Limited and Northland Capital Partners Limited as placing agents to Motif Bio Plc on a US$25m US IPO and European Placement

Tuesday 29 November 2016

Marriott Harrison LLP acted for Zeus Capital Limited and Northland Capital Partners Limited in their capacities as nominated adviser and broker and broker respectively to clinical stage pharmaceutical company Motif Bio Plc, which raised US$25m on an initial public offering of ADSs with warrants attached on NASDAQ and by an issue of new ordinary shares with warrants attached in Europe 

Corporate partners Simon Charles and Nils Reid advised Zeus Capital and Northland.